Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CCDC137 pseudogene 2 (CCDC137P2) is a pseudogene, classified as a non-coding genetic element that resembles the coding sequence of the coiled-coil domain containing 137 (CCDC137), but does not produce a functional protein product. Pseudogenes are generally not considered therapeutic targets as they typically lack biological function and are not involved in encoding functional proteins, receptors, or enzymes. Existing studies and databases focus only on the functional gene CCDC137, which has been implicated as a prognostic biomarker and oncogene in several cancers, correlating with immune cell infiltration and poor survival[1][2]. However, CCDC137P2 itself does not have demonstrated biological or disease relevance, is not targeted by drugs, does not serve as a biomarker, nor does it have known safety concerns for therapeutic intervention. If your query is intended to target a protein or functional gene, CCDC137P2 is not the correct entity; the biologically relevant target would be CCDC137 (coiled-coil domain containing 137)[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CCDC137 pseudogene 2 (CCDC137P2).